3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma LOVE

Cannara Biotech Inc.

LOVE TSX Biotech & Pharma

Stock factsheet

TickerLOVE
ExchangeTSX
ISIN
WKN
SectorBiotech & Pharma
Size class Micro Cap
Market capitalisation 131 Mio. USD As of 2026-08-04

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

Cannara Biotech Inc. ( TSX: LOVE ) ( OTCQX: LOVFF ) ( FRA: 8CB0 ), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products. Cannara owns two mega facilities based in Québec spanning over 1,600,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec's favourable energy costs, Cannara maintains an efficient, low-cost production model.

Company description as published by the issuer via TMX Money.

Share price

Price data from TradingView, possibly delayed. Not investment advice.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
Cannara Biotech Inc.LOVE TSX131 Mio. USD
Organigram Global Inc. OGITSX 132 Mio. USD
Custom Health Holdings Inc. CHLTTSX 122 Mio. USD
HealWELL AI Inc. Class A Subordinate Voting Shares AIDXTSX 141 Mio. USD
BioSyent Inc. RXTSXV 121 Mio. USD
DIRTT Environmental Solutions Ltd. DRTTSX 120 Mio. USD
Cardiol Therapeutics Inc. CRDLTSX 145 Mio. USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.